Back
Structure Therapeutics Stock Price Chart
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
GPCR
Structure Therapeutics
Last Price:
$21.08
Seasonality Move:
47.59%
7 Day Trial
ALL ACCESS PASS
$
7
Economy going through a "period of transition" - Your portfolio doesn't have to
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.74 | Buy |
| 20-day SMA: | 22.44 | Sell |
| 50-day SMA: | 25.55 | Sell |
| 200-day SMA: | 35.31 | Sell |
| 8-day EMA: | 21.63 | Buy |
| 20-day EMA: | 22.78 | Sell |
| 50-day EMA: | 25.52 | Sell |
| 200-day EMA: | 32.74 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.39 | Sell |
| Relative Strength Index (14 RSI): | 44.72 | Sell |
| Chaikin Money Flow: | 111531 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.03 - 25.33) | Sell |
| Bollinger Bands (100): | (24.42 - 35.84) | Sell |
Structure Therapeutics Technical Analysis
| Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 21.79 while GPCR 8-day simple moving average is 21.74, which is a Buy signal.
-
The stock price of GPCR is 21.79 while Structure Therapeutics 20-day SMA is 22.44, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 25.55 while GPCR share price is 21.79, making it a Sell technically.
-
GPCR stock price is 21.79 and Structure Therapeutics 200-day simple moving average is 35.31, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
33
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $21.79. The Score for GPCR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.2B
Price in USD:
21.79
Share Volume:
325.3K
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
19.39
Sell
33
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 21.79 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 21.79 while GPCR 8-day exponential moving average is 21.63, which is a Buy signal.
-
The stock price of GPCR is 21.79 while Structure Therapeutics 20-day EMA is 22.78, which makes it a Sell.
-
Structure Therapeutics 50-day exponential moving average is 25.52 while GPCR share price is 21.79, making it a Sell technically.
-
GPCR stock price is 21.79 and Structure Therapeutics 200-day simple moving average is 32.74, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.08 per share, and a decrease next year of $0.68 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is -1.39, suggesting Structure Therapeutics is a Sell
-
Structure Therapeutics Relative Strength Index (RSI) is 44.72, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (21.03 - 25.33), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (24.42 - 35.84), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.